Answers are grounded in this paper and cite their sources.
Case report shows cerebral venous sinus stenting restores vision in fulminant intracranial hypertension, suggesting its early use is safe and effective.
A 20-year-old woman with fulminant idiopathic intracranial hypertension (severe visual loss within 4 weeks of initial symptoms) was successfully managed with cerebral venous sinus stenting. She had presented with severe headache, vomiting and blurring of vision for 2 weeks. On examination, she had severe papilloedema with bilaterally constricted visual fields on perimetry. Because of persistent symptoms despite medical management, she underwent transcutaneous cerebral venous sinus stenting on day 7, with symptom relief 3 days later. On review at 7 months, she had complete resolution of papilloedema and restoration of normal visual fields. Cerebral venous sinus stenting performed early in fulminant idiopathic intracranial hypertension can give complete resolution of visual loss, with a good safety profile.
No takes yet. Share an insight, caveat, or question.
Babu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: